Delivery Order SPE2DB20D7066-SPE2DB26FC1LV
Award Date 10/28/25
Potential Completion Date 10/29/25
Potential Value $3.4K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The U.S. Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on August 20, 2025, for the supply of Procainamide 1 gram/10 mL vials with a ceiling value of $10,566.94. This firm fixed-price delivery order, with an ultimate completion date of August 21, 2025, represents a continuation of AmerisourceBergen's extensive federal pharmaceutical supply relationship. The contract was competitively awarded with no set-aside designation, consistent with the...
- The U.S. Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on August 15, 2025, for the supply of Procainamide 1 gram/10 milliliter vials with a ceiling value of $2,137.63. This is a firm fixed-price delivery order with an ultimate completion date of August 18, 2025, and represents a non-competitive, non-set-aside award. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Procainamide 1,000 mg/2 mL vials with a contract value of $6,203.12 and an ultimate completion date of July 31, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. Procainamide is an antiarrhythmic medication used to treat abnormal heart rhythms and is a critical pharmaceutical...
- The Defense Logistics Agency awarded a delivery order valued at $3,508.11 to AmerisourceBergen Drug Corp for the supply of Procainamide 1 gram/10 milliliter vials on August 27, 2025. This firm fixed price delivery order, with an ultimate completion date of August 28, 2025, represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (SPE2DX) with DLA Troop Support Medical, a $999.999 billion global pharmaceutical support vehicle running through December 2026. The...
- The Defense Logistics Agency awarded a $13,436.04 firm fixed-price delivery order to AmerisourceBergen Drug Corp for the supply of Procainamide 1 gram/2 mL vials on September 25, 2025, with completion scheduled for September 26, 2025. This non-competitive, non-set-aside award is being performed at the awardee's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a child contract issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA...
- The Defense Logistics Agency awarded a delivery order valued at $6,171.16 to AmerisourceBergen Drug Corp for the supply of Procainamide 1,000 mg/10 mL vials (10 mL quantity) on September 19, 2025, with an ultimate completion date of September 22, 2025. This firm fixed-price delivery order represents a non-set-aside competitive award and is performed out of the contractor's Conshohocken, Pennsylvania facility. The award is issued as a child delivery order under AmerisourceBergen's larger...
- The U.S. Defense Logistics Agency Medical Supply Chain awarded a $9,021.07 firm fixed-price delivery order to AmerisourceBergen Drug Corp on October 14, 2025, for the supply of Procainamide 1 gram/10 milliliter vials. The contract, which is non-set-aside and competitively awarded, is scheduled for completion by October 15, 2025, with performance taking place at the vendor's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a discrete transaction within...
- The U.S. Defense Logistics Agency (DLA) Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on August 11, 2025, for the supply of Procainamide 1 gram/10 mL vials. This competitive, non-set-aside award carries a ceiling value of $3,145.00 and is scheduled for completion by August 12, 2025. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location. This delivery...
- The U.S. Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on August 13, 2025, for the supply of Procainamide 1 gram/10 milliliter vials with a ceiling value of $3,164.53. This firm fixed-price delivery order, which is not set-aside, is scheduled for completion by August 14, 2025, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. The award represents a continuation of AmerisourceBergen's role as a critical...
- The U.S. Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp for Procainamide 1 gram/10 mL vials totaling $1,539.32 on September 4, 2025, with completion due by September 5, 2025. This competitively awarded, firm fixed-price delivery order represents a single pharmaceutical procurement under a larger contract vehicle. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor and critical...